Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 307 across all filing types
Latest filing 2024-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Lunit Inc., covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial data, business operations, risk management, and research activities, which are characteristic of an interim financial report. It is not a mere announcement or certification, but the full report itself. Q1 2024
2024-05-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (Macquarie Asia Conference 2024). It provides details such as date, location, purpose, and contact information. It does not contain the actual presentation slides or financial data, but rather announces the event and the availability of materials. Under the 'Menu vs Meal' rule, this is an announcement of an event/report, fitting the criteria for a Regulatory Filing (RNS) as it is a standard corporate disclosure of an IR activity.
2024-05-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identifies itself as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the number of shares granted due to employee departures. This falls under the category of general regulatory announcements regarding corporate actions that do not fit into specific categories like M&A or dividends, and is best classified as a Regulatory Filing (RNS).
2024-05-08 Korean
증권발행결과(자율공시) (제1회차 CB)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2024-05-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent amendment (정정신고) to the list of investors. This type of filing is a regulatory disclosure required by the Korea Exchange (KRX) for material corporate events, specifically capital raising through debt instruments. It does not fit into the 'Annual Report' or 'Earnings Release' categories, but rather falls under 'Capital/Financing Update' (CAP) as it details the terms, interest rates, and investor list for a convertible bond issuance.
2024-05-02 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 1% confidence The document is a formal regulatory filing titled '타법인 주식 및 출자증권 양수결정 정정신고' (Amendment to the Report on Acquisition of Shares and Securities of Another Corporation). It details a change in the expected acquisition date for Volpara Health Technologies Limited. This is a standard corporate disclosure filed with the Korea Exchange (KRX) regarding M&A activity. Since it specifically details the acquisition of another company, it falls under the M&A Activity category.
2024-04-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.